(A) Experimental design and gating strategy for the identification of major DC subpopulations that take up fluorescent OVA and migrate to the tLNs. An electronic gate was set on viable tLN-derived cells based on the physical properties size and granularity represented by forward scatter (FSC) und sideward scatter (SSC), respectively. A second electronic gate was set on CD11c+MHCII+ DCs, and cell surface expression of B220 was used to distinguish between B220low cDCs/MoDCs and B220hi pDCs. Uptake of fluorescent OVA by DCs in general as well as by both subpopulations is shown in fluorescence histograms. Shaded histograms represent controls performed with unlabeled OVA. (B) Quantitation of OVA-laden cells that migrated to the draining tLNs or ...
<p>(a) The number of FITC<sup>+</sup> MHC class II<sup>+</sup> DCs in the draining lymph nodes from ...
Item does not contain fulltextDendritic cells (DCs) are professional antigen presenting cells, well ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
The experimental design corresponds to that of Figs 9 and 10, using fluorescence-labeled OVA to rest...
(A) Experimental design and gating strategy: To assess antigen uptake by DCs and to track the DCs, C...
<p>Murine BMDCs were pulsed with OG-labeled antigens (each containing 2000 RFU) for 22.5, 45, or 90 ...
A 5 μm-pore transwell system (see S8 Fig for details) was used for monocyte migration assays. A) Rep...
<p>(A) Experimental design for diet regimen and induction of respiratory tolerance via intranasal ad...
<p>C57BL/6 mice were immunized by the vaginal or nasal route with OVA Alexa Fluor 647-conjugate (25 ...
<div><p>CTLs from OVA-vaccinated and mock-vaccinated mice were analyzed in parallel using an MHC arr...
<p>Mice were intranasally immunized with OVA either alone (open column) or with 500 µg of PMB (close...
<p>Murine BMDCs were pulsed with OG-labeled antigens (each containing 2000 RFU) in the presence or a...
Satellite cells were gated with an elliptical gate in a forward and side scatter plot to exclude cel...
<p>(<b>A</b>) BM-DC were incubated with indicated concentrations of OVA or OVA-Cl for 2 h at 37°C. W...
<p>(A) DCs were loaded localized in the middle compartment of the migration chamber in a collagen ge...
<p>(a) The number of FITC<sup>+</sup> MHC class II<sup>+</sup> DCs in the draining lymph nodes from ...
Item does not contain fulltextDendritic cells (DCs) are professional antigen presenting cells, well ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
The experimental design corresponds to that of Figs 9 and 10, using fluorescence-labeled OVA to rest...
(A) Experimental design and gating strategy: To assess antigen uptake by DCs and to track the DCs, C...
<p>Murine BMDCs were pulsed with OG-labeled antigens (each containing 2000 RFU) for 22.5, 45, or 90 ...
A 5 μm-pore transwell system (see S8 Fig for details) was used for monocyte migration assays. A) Rep...
<p>(A) Experimental design for diet regimen and induction of respiratory tolerance via intranasal ad...
<p>C57BL/6 mice were immunized by the vaginal or nasal route with OVA Alexa Fluor 647-conjugate (25 ...
<div><p>CTLs from OVA-vaccinated and mock-vaccinated mice were analyzed in parallel using an MHC arr...
<p>Mice were intranasally immunized with OVA either alone (open column) or with 500 µg of PMB (close...
<p>Murine BMDCs were pulsed with OG-labeled antigens (each containing 2000 RFU) in the presence or a...
Satellite cells were gated with an elliptical gate in a forward and side scatter plot to exclude cel...
<p>(<b>A</b>) BM-DC were incubated with indicated concentrations of OVA or OVA-Cl for 2 h at 37°C. W...
<p>(A) DCs were loaded localized in the middle compartment of the migration chamber in a collagen ge...
<p>(a) The number of FITC<sup>+</sup> MHC class II<sup>+</sup> DCs in the draining lymph nodes from ...
Item does not contain fulltextDendritic cells (DCs) are professional antigen presenting cells, well ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...